Pelvic plexiform neurofibroma in Recklinghausen disease

Kriger A.G.; Berelavichus S.V.; Poliakov I.S.; Varava A.B.; Son A.I.; Akhmedov B.G.; Galchina Yu.S.

doi:https://doi.org/10.17116/hirurgia2017390-93

Kriger A.G.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

ORCID: 0000-0002-4567-8312

Berelavichus S.V.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Poliakov I.S.

Institut khirurgii im. A.V. Vishnevskogo Minzdrava RF, Moskva

Varava A.B.

Vishnevsky National Medical Research Center of Surgery of Ministry of Health of Russia, Moscow, Russia

Son A.I.

A.V. Vishnevskiy Institute of Surgery, Health Ministry of the Russian Federation, Moscow

Akhmedov B.G.

Department of Orthopedics and Arthrology of A.V. Vishnevsky Institute of Surgery, Health Ministry of Russia, Moscow, Russia

Galchina Yu.S.

Vishnevsky Institute of Surgery, Moscow, Russia

Pelvic plexiform neurofibroma in Recklinghausen disease

Authors:

Kriger A.G., Berelavichus S.V., Poliakov I.S., Varava A.B., Son A.I., Akhmedov B.G., Galchina Yu.S.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2017;(3): 90‑93

DOI: 10.17116/hirurgia2017390-93

Read: 3868 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kriger AG, Berelavichus SV, Poliakov IS, Varava AB, Son AI, Akhmedov BG, Galchina YuS. Pelvic plexiform neurofibroma in Recklinghausen disease. Pirogov Russian Journal of Surgery. 2017;(3):90‑93. (In Russ.)
https://doi.org/10.17116/hirurgia2017390-93

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

A clinical case of type 1 neurofibromatosis associated with a rare genotype. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):128-132

Abstract:

Keywords:

pelvic plexiform neurofibroma

Recklinghausen disease

Authors:

Kriger A.G.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

ORCID: 0000-0002-4567-8312

Berelavichus S.V.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Poliakov I.S.

Institut khirurgii im. A.V. Vishnevskogo Minzdrava RF, Moskva

Varava A.B.

Vishnevsky National Medical Research Center of Surgery of Ministry of Health of Russia, Moscow, Russia

Son A.I.

A.V. Vishnevskiy Institute of Surgery, Health Ministry of the Russian Federation, Moscow

Akhmedov B.G.

Department of Orthopedics and Arthrology of A.V. Vishnevsky Institute of Surgery, Health Ministry of Russia, Moscow, Russia

Galchina Yu.S.

Vishnevsky Institute of Surgery, Moscow, Russia

Close metadata

References:

Demestre M, Herzberg J, Holtkamp N, Hagel C, Reuss D, Friedrich RE, Kluwe L, Von Deimling A, Mautner VF, Kurtz A. Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model. J Neurooncol. 2010;98:11-19. doi:10.1007/s11060-009-0049-4
Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet. 2002;39:311-314.
Jakacki RI, Dombi E, Potter DM, Goldman S, Allen JC, Pollack IF, Widemann BC. Phase I trial of pegylated interferon-alpha-2b in young patients with plexiform neurofibromas. Neurology. 2011;76:265-272. doi:10.1212/WNL.0b013e318207b031
Le LQ, Shipman T, Burns DK, Parada LF. Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas. Cell Stem Cell. 2009;4:453-463. doi:10.1016/j.stem.2009.03.017
McCaughan JA, Holloway SM, Davidson R, Lam WW. Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1. J Med Genet. 2007;44:463-466. doi:10.1136/jmg.2006.048140
von Recklinghausen, F. Uber die Multiplen Fibrome der Haut und ihre Beziehung zu Multiplen Neuromen. Berlin: August Hirschwald; 1882.
Widemann BC, Salzer WL, Arceci RJ, Blaney SM, Fox E, End D, Gillespie A, Whitcomb P, Palumbo JS, Pitney A, Jayaprakash N, Zannikos P, Balis FM. Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas. J Clin Oncol. 2006;24:507-516. doi:10.1200/JCO.2005.03.8638
Wu J, Dombi E, Jousma E, Scott Dunn R, Lindquist D, Schnell BM, Kim MO, Kim A, Widemann BC, Cripe TP, Ratner N. Preclincial testing of Sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging. Pediatr Blood Cancer. 2011. doi:10.1002/pbc.23015
Yang FC, Ingram DA, Chen S, Zhu Y, Yuan J, Li X, Yang X, Knowles S, Horn W, Li Y, Zhang S, Yang Y, Vakili ST, Yu M, Burns D, Robertson K, Hutchins G, Parada LF, Clapp DW. Nf1-dependent tumors require a microenvironment containing Nf1+/– and c-kit-dependent bone marrow. Cell. 2008;135:437-448. doi:10.1016/j.cell.2008.08.041